Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives.
about
Psychosocial assessment and monitoring in the new era of non-interferon-alpha hepatitis C virus treatmentsPreconception and contraceptive care for women living with HIVTransgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practicesThe future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practicesImpact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort studyEfavirenz in the therapy of HIV infection.Gonadal function and reproductive health in women with human immunodeficiency virus infection.High incidence of unplanned pregnancy after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa.Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188.Contraception in HIV-positive female adolescents.The Expanding Class of Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of HIV-1 InfectionCombined oral contraceptives and antiretroviral PK/PD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in MalawiPharmacokinetic interactions between the hormonal emergency contraception, levonorgestrel (Plan B), and EfavirenzRole of the Pharmacist in Caring for Patients with HIV/AIDS: Clinical Practice Guidelines.Contraceptive use among HIV-infected women and men receiving antiretroviral therapy in Lusaka, Zambia: a cross-sectional surveyComparative effectiveness of efavirenz-based antiretroviral regimens in resource-limited settingsCare of the human immunodeficiency virus-infected menopausal woman.Effect of injectable contraceptive use on response to antiretroviral therapy among women in Rakai, Uganda.Temporal Trends and Predictors of Modern Contraceptive Use in Lusaka, Zambia, 2004-2011.Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy.Effect of concurrent use of anti-retroviral therapy and levonorgestrel sub-dermal implant for contraception on CD4 counts: a prospective cohort study in Kenya.Contraception and HIV infection in women.Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age.Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients.Important Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs.Contraceptive options for HIV-positive women: making evidence-based, patient-centred decisions.The Importance of HIV Research for Transgender and Gender Non-Binary Individuals.Examining the contraceptive decisions of young, HIV-infected women: a qualitative study.Contraceptive, condom and dual method use at last coitus among perinatally and horizontally HIV-infected young women in Atlanta, Georgia
P2860
Q26784261-7025A91B-BF7C-48D0-BA87-95DC404FF62BQ27012918-06682B31-1EF6-4755-84D6-82CB148F68B0Q28067469-101DC760-A787-46EA-AA32-11BC2425D23FQ28072780-AE2D9410-4957-4937-87F9-1C42354F72A4Q33531746-1591E02A-20F6-45C1-A6C2-760098F14F2DQ33607011-A6155F9E-9163-4A22-8FE1-73F6A7E531FFQ34117651-3C88E17C-3402-4C83-9786-14CB95BED2DAQ34257078-8F49C390-A548-44FE-B76E-BF65EF77A6A3Q34338876-C534594F-E7D5-4325-B96B-2B39F113B4E7Q35068065-8F61CF93-9511-40D8-9479-B5E33FD2826DQ35111300-D56A7091-2F88-45B5-AF0C-8B5516D29E8AQ35222849-20E2EC6D-F9D7-4288-97A7-3FEB40444D36Q35821164-D09D3B8F-84AA-4EA4-8B9D-A2FE31690589Q35898538-21A8700D-C68F-4243-A38B-7D941D30A930Q36016655-379362AD-0FDA-4C81-B8D8-094F0762D4A5Q36031230-A2CB1ABB-7BA9-4B3B-AAE3-382BCC621F99Q36128333-B7652FC0-F7B3-4BEF-BC41-350B2D80D4B3Q36253176-B2A2E9DC-4993-4480-8EE7-8523F20D3E1EQ36446880-818CBD70-0908-4A97-9F69-22F41C4A1E54Q36566659-A1EFEFE7-87B3-426C-ABCA-2130642308CAQ36651855-DE23DB2D-A264-43C8-8B70-E54EC10760F0Q37090507-381FEEB5-F1D7-43CE-BEC3-F2F306717A9BQ37326983-3DBF747D-992B-4326-8F7B-43DAC8C80439Q37845854-F2242BCB-F538-48DE-B485-69D0A5215E0FQ37962449-81C54A69-C4FA-4CED-908E-800F34D2517DQ38358383-5B28CE93-8A6D-4C16-A260-E94E15132751Q46066001-049EDCE3-1EEB-4DB3-8046-5B2A4EF3E919Q53416812-6B2CADE5-2C30-437D-BCD7-D1D524A3D588Q58747976-663247C5-EECD-4D32-ABB1-5E01EB216368
P2860
Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives.
@en
Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives.
@nl
type
label
Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives.
@en
Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives.
@nl
prefLabel
Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives.
@en
Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives.
@nl
P2860
P1476
Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives.
@en
P2093
Jennifer M Cocohoba
Shareen Y El-Ibiary
P2860
P304
P356
10.1080/13625180701829952
P577
2008-06-01T00:00:00Z